Labiotech.eu

oxstem regenerative medicine stem cell leukemia

News and Trends 12 May 2016

Oxford Spin-Out Raises Record €21M to Re-Program Stem Cells

OxStem’s strategy for stem cells therapy inside the body could have a big impact in regenerative medicine – and it has raised €21.4M, a record for a UK spin-out. A spin-out of Oxford University, OxStem is developing cell programming therapies that could treat a range of usually age-related conditions – dementia, heart failure, macular degeneration, […]

May 12, 2016 - 2 minutesmins - By Denise Neves Gameiro

technical university munich tum catalysis synbio

News and Trends 11 May 2016

Artificial enzymes to be developed in Munich with new Synbio Programme

Biological systems that could produce insulin out of greenhouse gas – this is one of the goals of the new €11.5M Synthetic Biology programme, at the Technical University of Munich (TUM). The Technical University of Munich (TUM) has many research highlights, including CAR-T research with impressive results. It has recently created the TUM School of Bioengineering […]

May 11, 2016 - 2 minutesmins - By Denise Neves Gameiro

biotech nathalie moll europabio biotechnology

News and Trends 11 May 2016

EuropaBio: “We as an industry should be proud of what we do”

We just partnered with the European Biotech Week, which is a good reason to talk to its secretary general, Nathalie Moll. I asked her more about the event, the reasons for organising it and her vision for the future of Biotech in Europe. The event is a week of Biotech related seminars and activities from September 26th to October 2nd organised by […]

May 11, 2016 - 4 minutesmins - By Philip Hemme

News and Trends 11 May 2016

German mRNA specialist moves into Animal Health in collaboration with Bayer

BioNTech is joining its mRNA technology with Bayer’s expertise in veterinary applications in a new collaboration – to develop first-in-class vaccines for animals. Based in Mainz (Germany), BioNTech is the largest private Biotech in Europe. Along with its CAR-T and TCR programmes, BioNTech is developing mRNA therapies – a promising field in medicine. These include immunotherapies for […]

May 11, 2016 - 2 minutesmins - By Denise Neves Gameiro

Neovacs lupus erythmatosis kinoid cytokine world day biotech therapy

News and Trends 10 May 2016

Today is World Lupus Day! Meet the people who are fighting this Rare disease

World Lupus Day is an initiative to increase the awareness around this disease which affects more than 5 million people worldwide. Last week in Paris, the biotech company Neovacs, which develops an innovative therapy against lupus, had gathered researchers, entrepreneurs and patients’ associations who are fighting the disease. I was there to meet them and […]

May 10, 2016 - 6 minutesmins - By Joachim Eeckhout

News and Trends 10 May 2016

Life Sciences VC gets €204M in its Biggest Fundraiser Ever

MVM Capital has raised its fourth and largest funding round. It now has an additional €204M to invest in healthcare in the US and Europe. With offices in Boston and London, MVM Capital is an important VC in the healthcare sector – from biotechnology to medical devices. Its biggest success story is perhaps Heptares, a […]

May 10, 2016 - 2 minutesmins - By Denise Neves Gameiro

ergomed clinical trial smo operation andrew mackie drug development pipeline oncology autoimmune rare disease smo

News and Trends 10 May 2016

This UK Company told us how they Optimise Drug Development and turn a Profit

Drug development is complex, requiring a high level of many different skills as well as an insane amount of cash to put it on the market. Having an innovative business model can be one solution to make it affordable. That is what Ergomed, a profitable UK company is doing: combining Clinical Research Organisation (CRO) services and […]

May 10, 2016 - 4 minutesmins - By Dani Bancroft

bristol ieropoulos microbial fuel cell mfc urine

News and Trends 10 May 2016

British Researchers Stack Bacteria to Turn Urine into Electricity

Researchers from Bristol in the UK developed a new design of microbial fuel cells (MFCs), a more efficient way to use wastewater to produce electricity. Want to power your smartphone with your pee? Biotechnology has been diligently working on the idea for decades now, with microbial fuel cells (MFCs). A fuel cell is a technology that can […]

May 10, 2016 - 3 minutesmins - By Denise Neves Gameiro

novigenix colox clinical cancer research

News and Trends 9 May 2016

Swiss Blood Test for colorectal cancer joins race of ‘Liquid Biopsies’

Novigenix has published a validation study of its molecular blood test (Colox) which can reliably detect colorectal cancer at an early stage. Is this the second-place diagnostic in the race for Colorectal cancer blood tests? Based in Lausanne (Switzerland), Novigenix is developing molecular diagnostics from a new generation of predictive gene expression profiles and tumor-derived protein markers (biomarkers). Novigenix first […]

May 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 9 May 2016

Update: Cold Sore Season is Here! AiCuris might have a Herpes Cure

Update (09/05/2017): AiCuris has started a Phase II trial, PRIOH-1, with the oral version of its herpes cure pritelivir. Update (17/01/2017): The company has presented results from its first Phase II trial with pritelivir. The drug candidate proved to work better than the antiviral drug valacyclovir, currently the standard of care. Update (01/12/2017): AiCuris announced […]

May 9, 2016 - 2 minutesmins - By Evelyn Warner

allergy therapeutics birch pollen rhinitis biotech uk

News and Trends 9 May 2016

UK Biopharma joins Allergy race with good Phase II results for Hayfever

Allergy Therapeutics has gotten positive results for its phase II trial for birch pollen allergy – another win for their Pollinex platform. Based near Brighton (UK), Allergy Therapeutics has around 420 employees and has a market cap of €1.96M (£1.53M). Its focus is novel immunotherapies, with new technology for improving delivery and adjuvants – agents […]

May 9, 2016 - 2 minutesmins - By Denise Neves Gameiro

cellectis cancer leukemia ucart19 car t cell therapy GOSH baby second biotech

News and Trends 9 May 2016

Universal CAR-T given to Second baby with aggressive Leukemia

Once again, the French biotech Cellectis has hit headlines after having treated a second infant suffering from an aggressive form of Leukemia with their UCART19 therapy. Also based at the famous Great Ormond Street Hospital (GOSH) in London, another child has been treated with the first ever Universal CAR-T cell therapy. The child in question […]

May 9, 2016 - 2 minutesmins - By Dani Bancroft

Resources

Categories

The biggest private biotech investments in August 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

Six biotech companies that could revolutionize obesity treatments

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The biggest private biotech investments in August 2024

Long non-coding RNAs: what’s behind the growing “dark genome” buzz?

Grab your free report on 3D organoids and explore their future potential

Six biotech companies that could revolutionize obesity treatments

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Oxford Spin-Out Raises Record €21M to Re-Program Stem Cells

Artificial enzymes to be developed in Munich with new Synbio Programme

EuropaBio: “We as an industry should be proud of what we do”

German mRNA specialist moves into Animal Health in collaboration with Bayer

Today is World Lupus Day! Meet the people who are fighting this Rare disease

Life Sciences VC gets €204M in its Biggest Fundraiser Ever

This UK Company told us how they Optimise Drug Development and turn a Profit

British Researchers Stack Bacteria to Turn Urine into Electricity

Swiss Blood Test for colorectal cancer joins race of ‘Liquid Biopsies’

Update: Cold Sore Season is Here! AiCuris might have a Herpes Cure

UK Biopharma joins Allergy race with good Phase II results for Hayfever

Universal CAR-T given to Second baby with aggressive Leukemia

Subscribe to our newsletter to get the latest biotech news!